Retatrutide, by Soma Chems , is receiving increasing attention as a novel method for weight management . This unique drug combines the properties of a GLP-1 receptor agonist and a GIP receptor agonist , intended to simply promote weight loss but also address associated metabolic issues . Initial human trials have shown impressive outcomes , highlig